In this application we propose to develop microRNA and ultraconserved non coding RNA (UCR) biomarkers for the assessment of cancer risk and for the early detection of five different epithelial cancers, including the four most common malignant tumors (lung, breast, prostate, and colorectal cancer). A major reason, if not the major reason, of why these common epithelial tumors cause so much death and fail to respond to treatment is that by the time they are detected and diagnosed, the malignant cells have accumulated a large number of genetic and epigenetic alterations and have often acquired a """"""""mutator"""""""" phenotype. During the past five years, we have established the microRNA expression profiles and, in some cases the UCR expression profiles, of the major human epithelial malignancies. On the basis of this extensive experience, now we intend to assess whether microRNA and UCR dysregulation can be detected in the serum of individuals at risk of developing cancer and at risk of cancer progression in order to develop non invasive biomarkers of cancer risk and for early detection. Such biomarkers could then be also exploited to follow the success of therapy.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01CA152758-03
Application #
8294962
Study Section
Special Emphasis Panel (ZCA1-SRLB-C (M1))
Program Officer
Rinaudo, Jo Ann S
Project Start
2010-09-03
Project End
2015-06-30
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
3
Fiscal Year
2012
Total Cost
$354,255
Indirect Cost
$122,219
Name
Ohio State University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210
Pekarsky, Yuri; Balatti, Veronica; Palamarchuk, Alexey et al. (2016) Dysregulation of a family of short noncoding RNAs, tsRNAs, in human cancer. Proc Natl Acad Sci U S A 113:5071-6
Fong, Louise Y; Taccioli, Cristian; Jing, Ruiyan et al. (2016) MicroRNA dysregulation and esophageal cancer development depend on the extent of zinc dietary deficiency. Oncotarget 7:10723-38
Gaudio, Eugenio; Paduano, Francesco; Ngankeu, Apollinaire et al. (2016) A Fhit-mimetic peptide suppresses annexin A4-mediated chemoresistance to paclitaxel in lung cancer cells. Oncotarget 7:29927-36
Cataldo, Alessandra; Cheung, Douglas G; Balsari, Andrea et al. (2016) miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response. Oncotarget 7:786-97
Taccioli, Cristian; Garofalo, Michela; Chen, Hongping et al. (2015) Repression of Esophageal Neoplasia and Inflammatory Signaling by Anti-miR-31 Delivery In Vivo. J Natl Cancer Inst 107:
Di Leva, Gianpiero; Cheung, Douglas G; Croce, Carlo M (2015) miRNA clusters as therapeutic targets for hormone-resistant breast cancer. Expert Rev Endocrinol Metab 10:607-617
Kim, Taewan; Jeon, Young-Jun; Cui, Ri et al. (2015) Role of MYC-regulated long noncoding RNAs in cell cycle regulation and tumorigenesis. J Natl Cancer Inst 107:
Palmieri, Dario; Richmond, Timothy; Piovan, Claudia et al. (2015) Human anti-nucleolin recombinant immunoagent for cancer therapy. Proc Natl Acad Sci U S A 112:9418-23
Lee, Tae Jin; Haque, Farzin; Vieweger, Mario et al. (2015) Functional assays for specific targeting and delivery of RNA nanoparticles to brain tumor. Methods Mol Biol 1297:137-52
Cui, Ri; Kim, Taewan; Fassan, Matteo et al. (2015) MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7. Oncotarget 6:21802-15

Showing the most recent 10 out of 62 publications